Christopher Finn McQuaid (C Finn McQuaid, Christopher F McQuaid)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

BMC medicine

PLoS pathogens

BMJ open

The European respiratory journal

London School of Hygiene and Tropical Medicine

University of Bath (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

London School of Hygiene and Tropical Medicine Mar 15 2017

United Kingdom

Assistant Professor :: Infectious Disease Epidemiology

Rothamsted Research Jan 09 2013 - Mar 14 2017

United Kingdom

Post-doctoral Researcher :: Computational and Systems Biology

Education History

University of Bath Jan 09 2010 - Aug 31 2013

United Kingdom

PHD :: Mathematics

University of Bath Jan 09 2009 - Aug 31 2010

United Kingdom

MSC :: Mathematics

Rhodes University Jan 01 2008 - Dec 31 2008

South Africa

BSC :: Mathematics

Rhodes University Jan 01 2005 - Dec 31 2007

South Africa

BSC :: Mathematics and Chemistry

Publications

Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
Correction: The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
Correction: The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
Correction: The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Vester Gunsaru, Marc Yves Romain Henrion, Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC medicine 22 (1) (2024)
Degu Jerene, Jens Levy, Kristian van Kalmthout, Job van Rest, Christopher Finn McQuaid, Matthew Quaife, Salome Charalambous, Katya Gamazina, A M Celina Garfin, Liberate Mleoh, Yana Terleieva, Alexsey Bogdanov, Noriah Maraba, Katherine L Fielding
Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol. BMJ open 13 (3) (2023)
Degu Jerene, Jens Levy, Kristian van Kalmthout, Job van Rest, Christopher Finn McQuaid, Matthew Quaife, Salome Charalambous, Katya Gamazina, A M Celina Garfin, Liberate Mleoh, Yana Terleieva, Alexsey Bogdanov, Noriah Maraba, Katherine L Fielding
Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol. BMJ open 13 (3) (2023)
Jay Achar, James A Seddon, Gwenan Mary Knight, Peter J Dodd, Hanif Esmail, Jennifer Hughes, Christopher Finn McQuaid
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing. The European respiratory journal (2023)
Peter J Dodd, Christopher Finn McQuaid, Prasada Rao, Ibrahim Abubakar, Nimalan Arinaminpathy, Anna Carnegie, Frank Cobelens, David Dowdy, Kathy Fiekert, Alison D Grant, Jing Wu, Faith Nekabari Nfii, Nabila Shaikh, Rein M G J Houben, Richard G White
Improving the quality of the Global Burden of Disease tuberculosis estimates from the Institute for Health Metrics and Evaluation. International journal of epidemiology (2023)
Degu Jerene, Jens Levy, Kristian van Kalmthout, Job van Rest, Christopher Finn McQuaid, Matthew Quaife, Salome Charalambous, Katya Gamazina, A M Celina Garfin, Liberate Mleoh, Yana Terleieva, Alexsey Bogdanov, Noriah Maraba, Katherine L Fielding
Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol. BMJ open 13 (3) (2023)
Christopher Finn McQuaid, Marc Y R Henrion, Rachael M Burke, Peter MacPherson, Rebecca Nzawa-Soko, Katherine C Horton
Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries. BMC medicine 20 (1) (2022)
Chathika Krishan Weerasuriya, Rebecca Claire Harris, Christopher Finn McQuaid, Gabriela Beatriz Gomez, Richard G White
Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination. PLoS computational biology 18 (4) (2022)
Chathika Krishan Weerasuriya, Rebecca Claire Harris, Matthew Quaife, Christopher Finn McQuaid, Richard G White, Gabriela B Gomez
Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis. Vaccines 9 (3) (2021)
Christopher Finn McQuaid, Ted Cohen, Anna S Dean, Rein M G J Houben, Gwenan Mary Knight, Matteo Zignol, Richard G White
Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults. The European respiratory journal 57 (2) (2021)
Christopher Finn McQuaid, Christopher Aidan Gilligan, Frank van den Bosch
Considering behaviour to ensure the success of a disease control strategy. Royal Society open science 4 (12) (2017)
Christopher Finn McQuaid, Frank van den Bosch, Anna Maria Szyniszewska, Titus Alicai, Anthony Pariyo, Patrick Chiza Chikoti, Christopher Aidan Gilligan
Spatial dynamics and control of a crop pathogen with mixed-mode transmission. PLoS computational biology 13 (7) (2017)

Christopher Finn McQuaid.css-eqlu8i{font-size:small;padding-left:4px;} (C Finn McQuaid, Christopher F McQuaid)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher Finn McQuaid (C Finn McQuaid, Christopher F McQuaid)